None listed
Conditions
Brief summary
We have developed a smartphone App to support participation in decision-making for adults with stage 5 chronic kidney disease who are currently receiving haemodialysis. The App is called the SUCCESS App. It includes information about: • Diet • Fluids • Physical activity • Medicines • Emotional wellbeing • Supportive care • Health literacy skills The purpose of this study is to investigate whether the SUCCESS App supports adults with chronic kidney disease to make decisions about their health, and helps increase knowledge, skills and quality of life.
Interventions
Design: This is a multi-centre pragmatic randomized controlled trial with 0, 3, 6 and 12 month data collection points; both quantitative and qualitative methods will be used. Population: The study population consists of adults with Stage 5 chronic kidney disease who are currently receiving in-centre or home-based haemodialysis or peritoneal dialysis. Intervention: Participants who are randomized to the intervention will be invited to use the SUCCESS app for a maximum of 12 months. The SUCCESS app was designed to include informational content, covering diet, fluids, medicine, physical activity, emotional wellbeing and supportive care. Furthermore, the SUCCESS app includes features to improve the communicative and critical health literacy skills of patients across four domains: skills to a) access, b) understand, c) appraise and d) use/act on health information to make health decisions and be involved in self-management. Participants will be instructed to engage with the SUCCESS app as often as they would like. App analytics will be used the monitor the usage patterns of the app.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Stage 5 chronic kidney disease 2. Currently receiving haemodialysis at an in-patient or outpatient renal dialysis centre, home-based haemodialysis or peritoneal dialysis 3. Ability to read and speak English sufficiently well to respond to written questions without assistance 4 Ability to provide written informed consent.
Exclusion criteria
1. Unable to provide informed consent 2. Under 18 years